HIGHLIGHTS
- who: Paulina Czarnecka and collaborators from the Department of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of, Poland have published the article: Real-life comparison of efficacy and safety profiles of two prolonged-release tacrolimus formulations in de novo kidney transplant recipients: 24 months of follow-up, in the Journal: PLOS ONE of February/15,/2022
- what: The aim of this study was to compare the safety and efficacy profiles of once-daily LCPT and MR-4 Tac formulations in adult KTRs followed up for 24 months. The research showed similar NODAT incidents in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.